Enkephalin: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
== Pathophysiology == | == Pathophysiology == | ||
Due to the wide distribution of the endogenous opioid system in the human body, its dysregulation has a high number of implications. One example of pain dysregulation is fibromyalgia, which is a widespread pain in the absence of identifiable peripheral pathology <ref>Clauw D. J. (2014). Fibromyalgia: a clinical review. JAMA, 311(15), 1547–1555. https://doi.org/10.1001/jama.2014.3266</ref>. It appears that the endogenous opioid system is involved in some aspects of pain in fibromyalgia <ref name="schrepf">Schrepf, A., Harper, D. E., Harte, S. E., Wang, H., Ichesco, E., Hampson, J. P., Zubieta, J. K., Clauw, D. J., & Harris, R. E. (2016). Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain, 157(10), 2217–2225. https://doi.org/10.1097/j.pain.0000000000000633</ref>. The concentration of endogenous opioids in the cerebrospinal fluid (CSF) of patients with fibromyalgia seems to be higher, which leads to a decreased availability and affinity of Mu-opioid receptors (MOR) <ref name="schrepf"/>. This translates into an increase in pain neurotransmission. | |||
== Structure == | == Structure == | ||
